Skip to content

A prospective observational study of structure and visual field progression in open-angle glaucoma

A prospective observational study of structure and visual field progression in open-angle glaucoma - A prospective observational study of structure and visual field progression in open-angle glaucoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000012411
Enrollment
140
Registered
2013-11-29
Start date
2010-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

None listed

Sponsors

Santen Pharmaceutical CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subject who is willing to follow instruction, and has provided a written informed consent Diagnosis of open-angle glaucoma with glaucomatous visual field disorder in at least one eye In both eyes, gonioscopy grading of 3 or 4 in Shaffer classification

Exclusion criteria

Exclusion criteria: Subject who has a disease which considered inappropriate from safety perspective(severe cardiovascular/ respiratory/ hepatobiliary/ digestive/ urinary/ renal/ hematological/ endocrine/ immune disease, malignant tumor, etc.) The investigator, subinvestigator determined that the person is ineligible as study subject

Design outcomes

Primary

MeasureTime frame
MD Retinal nerve fiber layer

Countries

Japan

Contacts

Public ContactHisashi Kawata

Santen Pharmaceutical CO., LTD. Clinical Development Group

clinical@santen.co.jp06-4802-9338

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026